RPG Investment Advisory LLC Lowers Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

RPG Investment Advisory LLC lessened its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,631 shares of the exchange traded fund’s stock after selling 668 shares during the quarter. RPG Investment Advisory LLC’s holdings in SPDR S&P Biotech ETF were worth $2,308,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of the stock. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in SPDR S&P Biotech ETF by 198.6% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after buying an additional 6,138,000 shares during the period. Clal Insurance Enterprises Holdings Ltd purchased a new position in SPDR S&P Biotech ETF during the third quarter worth about $141,284,000. Mirae Asset Securities USA Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 50.0% in the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after purchasing an additional 300,000 shares during the period. Assetmark Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 72,653.0% in the third quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after purchasing an additional 588,489 shares during the period. Finally, Sivik Global Healthcare LLC purchased a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $29,640,000.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $91.70 on Monday. The firm has a 50 day simple moving average of $91.36 and a 200-day simple moving average of $96.00. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47. The firm has a market cap of $6.99 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.